Esophagoscopes & Gastroscopes Market Size & Share, by Product Type (AI-Integrated Gastroscopes, Standard Gastroscopes, Transnasal Esophagoscopes, Disposable Esophagoscopes); Application; Modality; End User - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

Esophagoscopes & Gastroscopes Market - Regional Analysis

North America Market Insights

North America is predicted to capture the highest share of 38.6% in the global market during the forecast tenure. The region benefits from its advanced healthcare infrastructure and expanded procedural volumes. The adoption of technology is at a surge, with 45.8% of hospitals in the U.S. currently using AI-based esophagoscopes & gastroscopes. On the other hand, USPTO denotes that the region hosts a substantial number of key players holding 63% of global patents for endoscopic imaging technologies, thus suitable for standard market growth.

The U.S. is stepping towards domination in the regional esophagoscopes & gastroscopes market with the huge reimbursement expansions and federal funding grants. CMS notes that Medicare expanded its coverage to 92.6% of surveillance endoscopies, reflecting a strong financial backup for patients. Whereas the adoption of AI is accelerating owing to the reduction in missed cancer rates, grabbing the interest of both service providers and consumers as well.  In 2023, federal funding surpassed USD 5.3 billion, prioritizing early cancer screenings, whereas the disposable scopes lower HAIs by 63% facilitating further development.

Canada is portraying steady growth in the esophagoscopes & gastroscopes market, with the presence of heavy public and private healthcare investments.  For instance, Ontario enhanced its spending by 19.8% for endoscopy units, reflecting its commitment towards quality healthcare. Meanwhile, in 2023, Health Canada allocated USD 3.5 billion to bridge the rural healthcare disparities that resulted in 46% of clinics currently equipped for advanced scopes. Furthermore, the PHAC guidelines led to a rise in single-use scope adoption, hence reducing reprocessing costs by 32.5%.

Europe Market Insights

Europe is readily augmenting in the market, attributed to the rising aging population and chronic disease burden. Exemplifying this, ECDC states that GERD affects 17% to 30% of adults in the region, providing a reliable consumer base for the sector. The region’s Medical Device Regulation led the adoption of AI-powered esophagoscopes & gastroscopes, where Germany and France dominate in terms of 4k imaging adoption. Furthermore, the disposable equipment is gaining traction owing to the nationwide mandates imposed, thus cutting infection rates by 55.3%.

Germany is the powerhouse of innovation in the esophagoscopes & gastroscopes market on account of government-led screening initiatives and AI-integration in most of the healthcare facilities. In this regard, the Federal Ministry of Health mandates yearly endoscopic surveillance for high-risk GERD and Barrett’s esophagus patients with a substantial 602.7 million annual fund that fuels 1.3 million additional procedures yearly. On the other hand, 63% of clinics in the country are anticipated to deploy AI endoscopy suites by the end of 2030, cementing Germany’s position as the leader in this landscape.

France also displays considerable growth in the esophagoscopes & gastroscopes market, facilitated by reimbursement policies and rural healthcare investments. The country’s National Authority of Health covers 92% of disposable scope costs, thereby accelerating 26% market penetration. Simultaneously, the PACTE’s 2025 plan allocated €404.4 million to deploy mobile endoscopy units in rural areas by targeting an additional 500,000 yearly procedures. Furthermore, the country’s Endo-AI Consortium received €120.6 million from both public and private systems leads in the EU trials for autonomous robotic scopes.

APAC Market Insights

Asia Pacific is likely to exhibit the fastest growth in the global esophagoscopes & gastroscopes market due to the escalating burden of gastroesophageal reflux disease and government-backed screening programs. Testifying to this fact, 14% to 26% of the population in the region is affected by the disease, displaying a wider consumer base for this sector.  Besides the notable expansion in the government reimbursement policies, screening programs are one of the major propagating factors in this landscape. Furthermore, the healthcare modernization in economies such as Japan, China, and India is also creating a sustained demand in this sector.

China is augmenting in the regional esophagoscopes & gastroscopes market with its massive government investments under the Healthy China 2030 initiative that allocated USD 2.2 billion yearly for endoscopic equipment as well as training. Furthermore, in 2023, the National Medical Products Administration significantly accelerated approvals for over 45 AI-powered endoscopy systems, thereby reducing diagnostic errors by 42% in clinical trials.  On the other hand, urban hospitals in the country record 1.9 million yearly procedures with a great revenue potential.

India is emerging in the global esophagoscopes & gastroscopes market, fueled by Ayushman Bharat’s funding that surpassed yearly 1.9 billion and endoscopy screenings in the public healthcare settings. The rural settings provide a great business opportunity since only 22.4% of primary healthcare centers offer endoscopy services, compelling over 63% of patients to move to urban settings. On the other hand, GERD instances are at the rise over the last decade, owing to dietary changes, thereby propelling 2.5 million yearly procedures.

Country-wise Government Provisions